Literature DB >> 7630349

Characterization of the glycolysis in lactate dehydrogenase-A deficiency.

H Miyajima1, Y Takahashi, E Kaneko.   

Abstract

Recurrent rhabdomyolysis due to decreased glycolysis occurred during strenuous exercise by patients with lactate dehydrogenase-A subunit (LDH-A; muscle) deficiency. We report the glycolytic features of 4 patients from 2 families in whom the severity of the disease differed. There was no difference in the gene abnormality. The enzyme activity of LDH in the muscle was less than 5% that of the control value. Glycolysis in the muscle showed that the respective sums of the pyruvate and lactate levels in the patients with mild and severe symptoms were reduced to approximately 65% and 35% that of the control value. Comparable amounts of glycerol 3-phosphate were produced. Glycerol 3-phosphate dehydrogenase activity in the muscles of patients with mild symptoms was three times the control value. These findings suggest that the disease severity in our patients may be related to the degree of NADH reoxidation by glycerol 3-phosphate dehydrogenase substituting for LDH.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7630349     DOI: 10.1002/mus.880180812

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

1.  Regional fat metabolism in human splanchnic and adipose tissues; the effect of exercise.

Authors:  Gerrit Van Hall; Jens Bülow; Massimo Sacchetti; Nariman Al Mulla; Dorthe Lyngso; Lene Simonsen
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

2.  Effects of lactate dehydrogenase suppression and glycerol-3-phosphate dehydrogenase overexpression on cellular metabolism.

Authors:  Dae-won Jeong; Il Taeg Cho; Tae Soo Kim; Gun Won Bae; Ik-Hwan Kim; Ick Young Kim
Journal:  Mol Cell Biochem       Date:  2006-02-14       Impact factor: 3.396

3.  Lactate dehydrogenase and glycerol-3-phosphate dehydrogenase cooperatively regulate growth and carbohydrate metabolism during Drosophila melanogaster larval development.

Authors:  Hongde Li; Madhulika Rai; Kasun Buddika; Maria C Sterrett; Arthur Luhur; Nader H Mahmoudzadeh; Cole R Julick; Rose C Pletcher; Geetanjali Chawla; Chelsea J Gosney; Anna K Burton; Jonathan A Karty; Kristi L Montooth; Nicholas S Sokol; Jason M Tennessen
Journal:  Development       Date:  2019-09-12       Impact factor: 6.868

Review 4.  [Rhabdomyolysis and myoglobinuria].

Authors:  A Lindner; S Zierz
Journal:  Nervenarzt       Date:  2003-05-14       Impact factor: 1.214

5.  Pharmacologic inhibition of lactate production prevents myofibroblast differentiation.

Authors:  Robert Matthew Kottmann; Emma Trawick; Jennifer L Judge; Lindsay A Wahl; Amali P Epa; Kristina M Owens; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-25       Impact factor: 5.464

6.  Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.

Authors:  Chengjung Lai; Natalie Pursell; Jessica Gierut; Utsav Saxena; Wei Zhou; Michael Dills; Rohan Diwanji; Chaitali Dutta; Martin Koser; Naim Nazef; Rachel Storr; Boyoung Kim; Cristina Martin-Higueras; Eduardo Salido; Weimin Wang; Marc Abrams; Henryk Dudek; Bob D Brown
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454

7.  Knockdown of lactate dehydrogenase by adeno-associated virus-delivered CRISPR/Cas9 system alleviates primary hyperoxaluria type 1.

Authors:  Rui Zheng; Xiaoliang Fang; Xi Chen; Yunteng Huang; Guofeng Xu; Lei He; Yueyan Li; Xuran Niu; Lei Yang; Liren Wang; Dali Li; Hongquan Geng
Journal:  Clin Transl Med       Date:  2020-12

8.  Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria.

Authors:  Gema Ariceta; Kelly Barrios; Bob D Brown; Bernd Hoppe; Ralf Rosskamp; Craig B Langman
Journal:  Kidney Int Rep       Date:  2021-02-03

9.  Reduction in urinary oxalate excretion in mouse models of Primary Hyperoxaluria by RNA interference inhibition of liver lactate dehydrogenase activity.

Authors:  Kyle D Wood; Ross P Holmes; David Erbe; Abigail Liebow; Sonia Fargue; John Knight
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-05-02       Impact factor: 5.187

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.